Cellectar Biosciences (CLRB) Prices $14.4M Public Offering at $4/Sh
Tweet Send to a Friend
Cellectar Biosciences (NASDAQ: CLRB) today announced the pricing of an underwritten public offering for gross proceeds of $14.4 million, prior ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
